Joseph E. Payne - 23 Nov 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
President and CEO, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
23 Nov 2022
Net transactions value
+$82,550
Form type
4
Filing time
28 Nov 2022, 15:07:25 UTC
Previous filing
23 Jun 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Purchase $82,550 +5,000 +0.34% $16.51 1,480,097 23 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction.